X-linked inhibitor of apoptosis
Ultimo aggiornamento 18 Ago 2020
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
L XIAP gene provides instructions for making a protein that is found in many types of cells, including immune cells. It helps protect these cells from self-destructing (undergoing apoptosis) by blocking (inhibiting) the action of certain enzymes called caspases, which are necessary for apoptosis. Specifically, the XIAP protein inhibits caspase enzymes 3, 7, and 9. The XIAP protein also plays a role in several other signaling pathways that are involved in various functions in the body.
Scelte video per GenesVideo library
Normal function
L XIAP gene provides instructions for making a protein that is found in many types of cells, including immune cells. It helps protect these cells from self-destructing (undergoing apoptosis) by blocking (inhibiting) the action of certain enzymes called caspases, which are necessary for apoptosis. Specifically, the XIAP protein inhibits caspase enzymes 3, 7, and 9. The XIAP protein also plays a role in several other signaling pathways that are involved in various functions in the body.
Conditions referring to this gene or chromosome
Altri nomi
API3
apoptosis inhibitor 3
baculoviral IAP repeat-containing protein 4
BIRC4
hILP
IAP-like protein, human
mammalian IAP homolog A
MIHA
X-linked inhibitor of apoptosis protein
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
XIAP_HUMAN
Related patient information and medicines

Patient information leaflet
distrofia muscolare di Duchenne
The muscle weakness is mainly in the 'proximal' muscles, which are those near the trunk of the body, around the hips and the shoulders. Farmaci called ACE inhibitors ACE inhibitors are recommended which slow down the progression of the disease and also prevent damage to heart muscle. Gene therapy The National Institute for Health and Care.

Patient information leaflet
Malattia renale diabetica
Trattamento aims to prevent or delay the progression of the malattia. Also, it aims to reduce the risk of developing cardiovascular diseases such as heart attack and stroke which are much more common than average in people with this disease. Diabetic kidney disease is one of the causes of chronic kidney disease Chronic kidney disease , a long-term.

Patient information leaflet
Sclerosi sistemica
Sclerosi sistemica is a type of scleroderma, which means hard skin. If you have scleroderma, you have areas of hardening of the skin. In systemic sclerosis, you can also get hardening of some of your internal organs. The... What is systemic sclerosis. Sclerosi sistemica is an autoimmune disease. This means that the immune system causes damage to.

Patient information leaflet
Malattia di Parkinson
The main sintomi di Malattia di Parkinson are usually stiffness, shaking (tremor), and slowness of movement. Treatment often provides good relief of symptoms for several years. Malattia di Parkinson is a progressive neurological degeneration of certain cells (called dopaminergic cells) within a specific part of the brain (substantia nigra). The.

Patient information leaflet
Emofilia
Emofilia is a rare bleeding disorder that affects your ability to make a clot. When you injure yourself the clot stops you bleeding. Haemophilia is a condition where there is a deficiency of clotting factors, so people with this condition usually have prolonged bleeding. There is no cure but with available treatments most people with.

Patient information leaflet
Posso prendere Esomeprazolo ed Ezetimibe insieme?
Non ci sono no known significant interactions between esomeprazole and ezetimibe. Perché succede Esomeprazole (a proton pump inhibitor) and ezetimibe (a cholesterol absorption inhibitor) work through different pathways in the body and do not significantly interfere with each other's absorption, metabolism, or excretion. What you should do You can.
Ulteriori letture e riferimenti
- X-linked inhibitor of apoptosis; MedlinePlus, National Library of Medicine.
- Holcik M, Gibson H, Korneluk RG. XIAP: apoptotic brake and promising therapeutic target. Apoptosis. 2001 Aug;6(4):253-61. doi: 10.1023/a:1011379307472.
- Latour S. Natural killer T cells and X-linked lymphoproliferative syndrome. Curr Opin Allergy Clin Immunol. 2007 Dec;7(6):510-4. doi: 10.1097/ACI.0b013e3282f1bad6.
- Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, Bleesing JJ, Zhang K, Filipovich AH. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010 Aug 19;116(7):1079-82. doi: 10.1182/blood-2010-01-256099. Epub 2010 May 20.
- Marsh RA, Villanueva J, Kim MO, Zhang K, Marmer D, Risma KA, Jordan MB, Bleesing JJ, Filipovich AH. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin Immunol. 2009 Jul;132(1):116-23. doi: 10.1016/j.clim.2009.03.517. Epub 2009 Apr 23.
- Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006 Nov 2;444(7115):110-4. doi: 10.1038/nature05257.
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

